A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration 

The price tag for PlanB One-Step, an emergency contraceptive pill, is seen at a CVS Pharmacy in Washington, U.S., July 7, 2022. REUTERS/Sarah Silbiger 

A package of PlanB One-Step, an emergency contraceptive pill, is seen in security packaging at a CVS Pharmacy in Washington, U.S., July 7, 2022. REUTERS/Sarah Silbiger 

The price tag for PlanB One-Step, an emergency contraceptive pill, is seen at a CVS Pharmacy in Washington, U.S., July 7, 2022. REUTERS/Sarah Silbiger 

A package of PlanB One-Step, an emergency contraceptive pill, is seen in security packaging at a CVS Pharmacy in Washington, U.S., July 7, 2022. REUTERS/Sarah Silbiger 

A package of PlanB One-Step, an emergency contraceptive pill, is seen in security packaging at a CVS Pharmacy in Washington, U.S., July 7, 2022. REUTERS/Sarah Silbiger 

A package of PlanB One-Step, an emergency contraceptive pill, is seen in security packaging at a CVS Pharmacy in Washington, U.S., July 7, 2022. REUTERS/Sarah Silbiger 

Birth-control pills are seen on display on a table at a gynaecologist clinic in Paris, France, January 5, 2022. REUTERS/Noemie Olive 

Birth-control pills are seen on display on a table at a gynaecologist clinic in Paris, France, January 5, 2022. REUTERS/Noemie Olive 

Venezuela's food shortages, inflation and crumbling medical sector have become such a source of anguish that a growing number of young women are reluctantly opting for sterilizations rather than face the hardship of pregnancy and child-rearing. Traditional contraceptives like condoms or birth control pills have virtually vanished from store shelves, pushing women towards the hard-to-reverse surgery. While no recent national statistics on sterilizations are available, doctors and health workers say demand for the procedure is growing. REUTERS/Carlos Garcia Rawlins SEARCH "STERILIZATION CHILD" FOR THIS STORY. SEARCH "THE WIDER IMAGE" FOR ALL STORIES. TPX IMAGES OF THE DAY Matching text VENEZUELA-STERILIZATIONS/ 

A Likhaan NGO health worker shows contraceptive pills to housewives during a family planning lecture at a reproductive health clinic in Tondo, metro Manila, Philippines January 12, 2016. In a statement, United Nations Population Fund (UNFPA) Country Representative Klaus Beck said, poor women in the Philippines who depend on free contraceptives from public health centres will be most impacted by the scrapping of government's budget for contraceptives. Picture taken January 12, 2016. REUTERS/Janis Alano 

A Plan B One-Step emergency contraceptive box is seen in New York, April 5, 2013. A federal judge on Friday ordered the U.S. Food and Drug Administration to make "morning-after" emergency contraception pills available without a prescription to all girls of reproductive age. REUTERS/Shannon Stapleton (UNITED STATES - Tags: HEALTH) 

An illustration picture shows blister-packs and a box of acne drug Diane-35, which is also used as a contraceptive, in a pharmacy in Andernos, Southwestern France, January 30, 2013. France's health regulator on Wednesday said it would suspend acne pill Diane 35 and its generic versions within three months because it carries a high risk of blood clots. REUTERS/Regis Duvignau (FRANCE - Tags: HEALTH) 

Dominique Maraninchi, General Director of the French National Security Agency for Medicines and Health Products (ANSM), speaks during a news conference at the agency's headquarter in Saint Denis, near Paris, January 30, 2013. France's health regulator on Wednesday said it would suspend acne pill Diane 35, which is also used as a contraceptive, and its generic versions within three months because it carries a high risk of blood clots. REUTERS/Philippe Wojazer (FRANCE - Tags: HEALTH HEADSHOT) 

Dominique Maraninchi (2ndR), General Director of the French National Security Agency for Medicines and Health Products (ANSM), speaks during a news conference at the agency's headquarter in Saint Denis, near Paris, January 30, 2013. France's health regulator on Wednesday said it would suspend acne pill Diane 35, which is also used as a contraceptive, and its generic versions within three months because it carries a high risk of blood clots. REUTERS/Philippe Wojazer (FRANCE - Tags: HEALTH) 

Dominique Maraninchi (L), General Director of the French National Security Agency for Medicines and Health Products (ANSM), speaks to the journalists after a news conference at the agency's headquarter in Saint Denis, near Paris, January 30, 2013. France's health regulator on Wednesday said it would suspend acne pill Diane 35, which is also used as a contraceptive, and its generic versions within three months because it carries a high risk of blood clots. REUTERS/Philippe Wojazer (FRANCE - Tags: HEALTH) 

An illustration picture shows blister-packs and a box of acne drug Diane-35, which is also used as a contraceptive, in a pharmacy in Andernos, Southwestern France, January 30, 2013. France's health regulator on Wednesday said it would suspend acne pill Diane 35 and its generic versions within three months because it carries a high risk of blood clots. REUTERS/Regis Duvignau (FRANCE - Tags: HEALTH) 

Dominique Maraninchi (L), General Director of the French National Security Agency for Medicines and Health Products (ANSM), speaks to the journalists after a news conference at the agency's headquarter in Saint Denis, near Paris, January 30, 2013. France's health regulator on Wednesday said it would suspend acne pill Diane 35, which is also used as a contraceptive, and its generic versions within three months because it carries a high risk of blood clots. REUTERS/Philippe Wojazer (FRANCE - Tags: HEALTH) 

Dominique Maraninchi (R), General Director of the French National Security Agency for Medicines and Health Products (ANSM), speaks to the journalists after a news conference at the agency's headquarter in Saint Denis, near Paris, January 30, 2013. France's health regulator on Wednesday said it would suspend acne pill Diane 35, which is also used as a contraceptive, and its generic versions within three months because it carries a high risk of blood clots. REUTERS/Philippe Wojazer (FRANCE - Tags: HEALTH) 

An illustration picture shows boxes of acne drug Diane-35, which is also used as a contraceptive, in a pharmacy in Andernos, Southwestern France, January 30, 2013. France's health regulator on Wednesday said it would suspend acne pill Diane 35 and its generic versions within three months because it carries a high risk of blood clots. REUTERS/Regis Duvignau (FRANCE - Tags: HEALTH) 

An illustration picture shows a box and blister-packs of acne drug Diane-35, which is also used as a contraceptive, in a pharmacy in Andernos, Southwestern France, January 30, 2013. France's health regulator on Wednesday said it would suspend acne pill Diane 35 and its generic versions within three months because it carries a high risk of blood clots. REUTERS/Regis Duvignau (FRANCE - Tags: HEALTH) 

A chemist holds a box of acne drug Diane-35, which is also used as a contraceptive, in a pharmacy in Andernos, Southwestern France, January 30, 2013. France's health regulator on Wednesday said it would suspend acne pill Diane 35 and its generic versions within three months because it carries a high risk of blood clots. REUTERS/Regis Duvignau (FRANCE - Tags: HEALTH) 

An illustration picture shows a box and blister-packs of acne drug Diane-35, which is also used as a contraceptive, in a pharmacy in Andernos, Southwestern France, January 30, 2013. France's health regulator on Wednesday said it would suspend acne pill Diane 35 and its generic versions within three months because it carries a high risk of blood clots. REUTERS/Regis Duvignau (FRANCE - Tags: HEALTH) 

An illustration picture shows a box and blister-packs of acne drug Diane-35, which is also used as a contraceptive, in a pharmacy in Andernos, Southwestern France, January 30, 2013. France's health regulator on Wednesday said it would suspend acne pill Diane 35 and its generic versions within three months because it carries a high risk of blood clots. REUTERS/Regis Duvignau (FRANCE - Tags: HEALTH) 

A chemist holds a box and blister-packs of acne drug Diane-35, which is also used as a contraceptive, in a pharmacy in Andernos, Southwestern France, January 30, 2013. France's health regulator on Wednesday said it would suspend acne pill Diane 35 and its generic versions within three months because it carries a high risk of blood clots. REUTERS/Regis Duvignau (FRANCE - Tags: HEALTH) 

A chemist holds a box of acne drug Diane-35, which is also used as a contraceptive, in a pharmacy in Andernos, Southwestern France, January 30, 2013. France's health regulator on Wednesday said it would suspend acne pill Diane 35 and its generic versions within three months because it carries a high risk of blood clots. REUTERS/Regis Duvignau (FRANCE - Tags: HEALTH) 

An illustration picture shows a woman holding a birth control pill at her home in Nice January 3, 2013. French health regulators are studying limiting the use of contraceptive pills that carry health risks and will stop reimbursing prescription costs of some types from March, after a woman sued drugmaker Bayer over alleged side-effects. An inquiry launched this week by the ANSM health regulator will review prescription practices by doctors, whom it says may be over-prescribing higher-risk third and fourth-generation pills. REUTERS/Eric Gaillard (FRANCE - Tags: HEALTH) 

An illustration picture shows a blister-pack of birth control pills displayed at a private home in Nice January 3, 2013. French health regulators are studying limiting the use of contraceptive pills that carry health risks and will stop reimbursing prescription costs of some types from March, after a woman sued drugmaker Bayer over alleged side-effects. An inquiry launched this week by the ANSM health regulator will review prescription practices by doctors, whom it says may be over-prescribing higher-risk third and fourth-generation pills. REUTERS/Eric Gaillard (FRANCE - Tags: HEALTH) 

An illustration picture shows a woman holding a birth control pill at her home in Nice January 3, 2013. French health regulators are studying limiting the use of contraceptive pills that carry health risks and will stop reimbursing prescription costs of some types from March, after a woman sued drugmaker Bayer over alleged side-effects. An inquiry launched this week by the ANSM health regulator will review prescription practices by doctors, whom it says may be over-prescribing higher-risk third and fourth-generation pills. REUTERS/Eric Gaillard (FRANCE - Tags: HEALTH) 

Health workers show the proper use of a condom during a family planning session held in the Likhaan centre, an NGO clinic in Tondo, Manila August 6, 2012. The housewives, who brought along their children, reacted enthusiastically to the session. After attendance, they are offered free contraception, such as pills or condoms. Pitting himself against the teachings of the country's powerful Catholic church, Philippine President Benigno Aquino, a Catholic like 80 percent of the population, has thrown his support behind a reproductive health bill that will, if passed, guarantee access to free birth control and promote sex education. Picture taken August 6, 2012. REUTERS/Erik De Castro (PHILIPPINES - Tags: POLITICS HEALTH SOCIETY POVERTY)

ATTENTION EDITORS: PICTURE 15 OF 27 FOR PACKAGE 'CONTRACEPTION, STATE AND CHURCH' SEARCH 'REPRODUCTIVE HEALTH' FOR ALL IMAGES 

Drugstore vendors display contraceptive pills and condoms they are selling in a slum community of Baseco, in Tondo, Manila September 30, 2012. REUTERS/Erik De Castro (PHILIPPINES - Tags: POLITICS HEALTH SOCIETY POVERTY) 

An NGO health worker holds contraceptive pills during a family planning session with housewives availing free pills in Tondo, Manila August 6, 2012. REUTERS/Erik De Castro (PHILIPPINES - Tags: POLITICS HEALTH SOCIETY POVERTY) 

Housewives receive birth control pills from a community health worker from the Likhaan non-governmental organisation (NGO) in Tondo, Manila August 6, 2012. Philippine President Benigno Aquino on Monday successfully threw his weight behind a health bill promoting state-funded contraception, stepping out of his late mother Corazon's shadow as he pushes reforms widely opposed by the Roman Catholic Church. The bill, as it stands, requires governments down to the village level to provide free or low-cost reproductive health services. The law will not promote abortion, which is illegal. REUTERS/Erik De Castro (PHILIPPINES - Tags: POLITICS HEALTH) 

Vienna born U.S. chemist, novelist and playwright Carl Djerassi, known for the development of the first oral contraceptive pill, takes a seat at a meeting with the Austrian Chancellor (not pictured) in Vienna October 20, 2009. REUTERS/Heinz-Peter Bader (AUSTRIA) 

Vienna born U.S. chemist, novelist and playwright Carl Djerassi, known for the development of the first oral contraceptive pill, displays his Austrian passport during a news conference in Vienna November 11, 2008. REUTERS/Heinz-Peter Bader (AUSTRIA) 

Vienna born U.S. chemist, novelist and playwright Carl Djerassi, known for the development of the first oral contraceptive pill, talks during a news conference in Vienna November 11, 2008. REUTERS/Heinz-Peter Bader (AUSTRIA) 

Vienna born U.S. chemist, novelist and playwright Carl Djerassi, known for the development of the first oral contraceptive pill, talks during a news conference in Vienna November 11, 2008. REUTERS/Heinz-Peter Bader (AUSTRIA)